您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(理学版)》

《山东大学学报(理学版)》 ›› 2025, Vol. 60 ›› Issue (9): 10-23.doi: 10.6040/j.issn.1671-9352.0.2025.069

• • 上一篇    

基于UPLC-QE-Orbitrap-MS技术的龙血竭成分定性定量分析

宁书怡,戴召媛,冯心池*   

  1. 天津中医药大学中药学院, 天津 301617
  • 发布日期:2025-09-10
  • 通讯作者: 冯心池(1988— ),女,副教授,博士,研究方向为中药学. E-mail:xiaochi0211@163.com
  • 作者简介:宁书怡(1999— ),女,硕士研究生,研究方向为中药分析化学. E-mail:ningshuyi0920@126.com*通信作者:冯心池(1988— ),女,副教授,博士,研究方向为中药学. E-mail:xiaochi0211@163.com
  • 基金资助:
    国家自然科学基金资助项目(82374140)

Chemical composition analysis and the determination of main components of Resina Draconis based on UPLC-QE-Orbitrap-MS

NING Shuyi, DAI Zhaoyuan, FENG Xinchi*   

  1. School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
  • Published:2025-09-10

摘要: 基于超高效液相色谱-四极杆-静电场轨道阱高分辨质谱(UPLC-QE-Orbitrap-MS)技术鉴定龙血竭中的化学成分,并建立同时测定龙血竭中主要成分含量的分析方法。采用色谱柱为ACQUITY UPLC BEH C18(1.7 μm, 2.1×100 mm),含0.1%甲酸的乙腈-水为流动相,高能电喷雾离子源(HESI),负离子模式扫描。结合各化合物的精确分子质量、二级质谱碎片信息和文献报道数据及对照品比对,鉴定龙血竭中的化学成分。建立基于UPLC-QE-Orbitrap-MS技术同时测定龙血竭中龙血素A、龙血素B、龙血素C、龙血素D、白藜芦醇和7,4'-二羟基黄酮质量分数的分析方法。定量分析方法以0.1%甲酸水(A)与0.1%甲酸乙腈(B)为流动相。梯度洗脱程序:0~2 min, 22%~45%B; 2~6 min, 45%B; 6~7 min, 45%~95%B; 7~8 min, 95%~22%B; 8~11 min, 22%B。流速为0.25 mL/min;柱温为35 ℃;进样量为5 μL。HESI源,负离子模式下平行反应监测(parallel reaction monitoring, PRM)扫描,毛细管温度为350 ℃,喷雾电压为2.8 kV,S-透镜水平为35 kV,鞘气流速为35 arb,辅助气流速为10 arb。结果表明,在龙血竭药材中,鉴定出25个化合物,其中黄酮类化合物22个,二苯乙烯类化合物3个,共9个化合物经与对照品比对而准确鉴定。选择龙血素A、龙血素B、龙血素C、龙血素D、白藜芦醇和7,4'-二羟基黄酮为质量分数测定的指标成分,6个成分在各自的质量浓度范围内线性关系良好(r≥0.999 2),精密度、重复性、稳定性均符合相关要求,加样回收率为92.2%~105.0%。对14批龙血竭药材进行质量分数测定,方法可行。龙血素B在龙血竭中的质量分数为0.41%~7.25%,是6个指标成分中质量分数最高的化学物质。综上,本研究在龙血竭化学成分系统分析的基础上,建立6种主要成分的质量分数测定方法,为龙血竭的药效物质基础与质量控制提供参考。

关键词: 龙血竭, 超高效液相色谱-四极杆-静电场轨道阱高分辨质谱(UPLC-QE-Orbitrap-MS), 质量控制, 黄酮类成分, 龙血素B

Abstract: Based on UPLC-QE-Orbitrap-MS, the chemical components of Resina Draconis were identified and the analytical method was established for simultaneous determination of the main components in Resina Draconis. The chromatographic column employed is an ACQUITY UPLC BEH C18(1.7 μm, 2.1×100 mm)column, utilizing a mobile phase of acetonitrile-water containing 0.1% formic acid. A high-energy electrospray ionization source(HESI)used and negative ion mode scanning was applied. By integrating the precise molecular masses of each compound, the fragment information from secondary mass spectrometry, the data reported in the literature, and comparisons with reference substances, the chemical components of Resina Draconis were identified, and a method for the simultaneous determination of the mass fractions of loureirin A, loureirin B, loureirin C, loureirin D, resveratrol, and 7,4'-dihydroxyflavone in Resina Draconis was established based on UPLC-QE-Orbitrap-MS technique. The quantitative analysis method used 0.1% formic acid water(A)and 0.1% formic acid acetonitrile(B)as mobile phase, gradient elution program: 0-2 min, 22%-45%B; 2-6 min, 45%B; 6-7 min, 45%-95%B; 7-8 min, 95%-22%B; 8-11 min, 22%B. Flow rate was set as 0.25 mL/min and column temperature was set as 35 ℃. The inject volume was set as 5 μL. HESI source and parallel reaction monitoring(PRM)scan in negative ion mode was applied, with capillary temperature set as 350 ℃, spray voltage set as 2.8 kV, S-lens level set as 35 kV, sheath gas flow rate set as 35 arb, auxiliary gas flow rate set as 10 arb. The results showed that 25 compounds, 22 flavonoids and 3 stilbenes were identified, 9 of which were compared with the reference standard and identified exactly. Loureirin A, loureirin B, loureirin C, loureirin D, resveratrol, and 7,4'-dihydroxyflavone were determined to be the index components of mass fractions. The linear relationship between the six components was good(r≥0.999 2)in the mass concentration range, and the precision, repeatability and stability met the relevant requirements. The recoveries were 92.2%-105.0%. The method was feasible to determine the mass fractions of 14 batches of Resina Draconis. The mass fractions of loureirin B is 0.41%-7.25%, which is the highest component among the 6 index components. In summary, based on systematic analysis of the chemical components of Resina Draconis, the mass fractions determination methods of 6 main components were established in this study to provide reference for the pharmacodynamic material basis and quality control of Resina Draconis.

Key words: Resina Draconis, UPLC-QE-Orbitrap-MS, quality control, flavonoids, loureirin B

中图分类号: 

  • R284
[1] 杨敏,杨瑞,覃彬华,等. 民族药龙血竭研究进展[J]. 海峡药学,2019,31(11):49-52. YANG Min, YANG Rui, QIN Binhua, et al. Research progress of dragons blood, a national medicine [J]. Strait Pharmaceutical Journal, 2019, 31(11):49-52.
[2] 徐红英,张晓燕. 中药血竭研究进展[J]. 中医药学报,2011,39(4):101-103. XU Hongying, ZHANG Xiaoyan. Research progress of dragons blood[J]. Acta Chinese Medicine and Pharmacology, 2011, 39(4):101-103.
[3] FAN J Y, YI T, SZE-TO C M, et al. A systematic review of the botanical, phytochemical and pharmacological profile of Dracaena cochinchinensis, a plant source of the ethnomedicine “dragons blood” [J]. Molecules, 2014,19(7):10650-10669.
[4] 孙晶,庞道然,郑姣,等. 龙血竭的药理、临床及质量控制研究进展[J]. 中国医院用药评价与分析,2017,17(11):1445-1447. SUN Jing, PANG Daoran, ZHENG Jiao, et al. Research progress in pharmacology, clinic and quality control of dragons blood[J]. Evaluation and Analysis of Drug-Use in Hospitals of China, 2017, 17(11):1445-1447.
[5] 国家药典委员会. 中华人民共和国药典:一部[M]. 北京:中国医药科技出版社,2020. Chinese Pharmacopoeia Commission. Pharmacopoeia of the Peoples Republic of China: part I [M]. Beijing: China Medical Science and Technology Press, 2020.
[6] 林忆龙,文亦磊,黄洪,等. 龙血竭化学成分及药理作用研究进展[J]. 中国民族民间医药,2020,29(6):50-55. LIN Yilong, WEN Yilei, HUANG Hong, et al. Research progress on chemical constituents and pharmacological effects of dragons blood[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2020, 29(6):50-55.
[7] 王建壮,吕华冲. 比色法测定龙血竭总黄酮含量[J]. 中国实验方剂学杂志,2013,19(16):55-58. WANG Jianzhuang, LV Huachong. content determination of total flavonoids in Resina Draconis by colorimetric method[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2013, 19(16):55-58.
[8] 李竣,朱功俊,陈素,等. HPLC法同时测定不同产地龙血竭中3种黄酮类成分[J]. 中南民族大学学报(自然科学版),2017,36(2):45-48. LI Jun, ZHU Gongjun, CHEN Su, et al. Simultaneous determination of three kinds of flavonoids in Resina Draconis from different regions by HPLC[J]. Journal of South-Central University for Nationalities(Natural Science Edition), 2017, 36(2):45-48.
[9] 李云,萧伟,秦建平,等. HPLC测定龙血竭提取物中龙血素A, B和7,4'-二羟基黄酮的含量[J]. 中国实验方剂学杂志, 2012, 18(3):45-47. LI Yun, XIAO Wei, QIN Jianping, et al. Determination of loureirin A, B and 7,4'-dihydroxy flavone in extract of Resina Draconis by HPLC[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2012, 18(3):45-47.
[10] 张静泽,胡迎庆,郭鹏. 紫外分光光度法测定龙血竭中二氢查耳酮的含量[J]. 中成药,2004,26(6):77-79. ZHANG Jingze, HU Yingqing, GUO Peng. Determination of dihydrochalcone in dragons blood by ultraviolet spectrophotometry[J]. Chinese Traditional Patent Medicine, 2004, 26(6):77-79.
[11] WANG S, LI Y W, ZHANG N X, et al. Screening of ESR2-targeted anti-postmenopausal osteoporosis chemistry from Rehmanniae Radix Preparata based on affinity ultrafiltration with UPLC-QE-Orbitrap-MS[J]. Journal of Chromatography B, 2025, 1251:124419.
[12] ZHANG K Y, LI C N, ZHANG N X, et al. UPLC-QE-orbitrap-based cell metabolomics and network pharmacology to reveal the mechanism of N-benzylhexadecanamide isolated from maca(Lepidium meyenii walp.)against testicular dysfunction[J]. Molecules, 2023, 28(10):4064.
[13] 李涛,谭璐,徐文泱,等. UPLC-Q/Orbitrap MS法检测水产品中12种抗生素残留[J]. 食品工业,2020,41(5):300-303. LI Tao, TAN Lu, XU Wenyang, et al. Determination of 12 kinds of antibiotics in aquatic products by UPLC-Q/orbitrap MS[J]. The Food Industry, 2020, 41(5):300-303.
[14] 汤钜添,陈少茹,张诚光. 基于UPLC-QE-Orbitrap-MS技术鉴定中药三棱入血成分[J]. 深圳中西医结合杂志,2024,34(5):72-74. TANG Jutian, CHEN Shaoru, ZHANG Chengguang. Identification of blood components of rhizoma sparganii based on UPLC-QE-orbitrap-MS technology[J]. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 2024, 34(5):72-74.
[15] 国家药典委员会. 中华人民共和国药典:四部[M]. 北京:中国医药科技出版社,2020. Chinese Pharmacopoeia Commission. Pharmacopoeia of the Peoples Republic of China: part IV[M]. Beijing: China Medical Science and Technology Press, 2020.
[16] JIANG Y, ZHANG G P, YAN D, et al. Bioactivity-guided fractionation of the traditional Chinese medicine Resina Draconis reveals loureirin B as a PAI-1 inhibitor[J]. Evidence-Based Complementary and Alternative Medicine, 2017, 2017:9425963.
[17] BAI X Z, HE T, LIU J Q, et al. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scarvia TGF-β/Smad pathway[J]. Experimental Dermatology, 2015, 24(5):355-360.
[18] HU J P, ZHANG R, TANG M, et al. Loureirin B inhibits the proliferation of hepatic stellate cells and the Wnt/β-catenin signaling pathway by regulating miR-148-3p[J]. Cellular & Molecular Biology Letters, 2018, 23:35.
[19] LI R, JIA H Y, SI M, et al. Loureirin B protects against cerebral ischemia/reperfusion injury through modulating M1/M2 microglial polarization via STAT6/NF-kappaB signaling pathway[J]. European Journal of Pharmacology, 2023, 953:175860.
[20] FANG H W, DING Y T, XIA S J, et al. Loureirin B promotes insulin secretion through GLP-1R and AKT/PDX1 pathways[J]. European Journal of Pharmacology, 2022, 936:175377.
[21] SHI S J, ZHAO Q R, KE C H, et al. Loureirin B exerts its immunosuppressive effects by inhibiting STIM1/Orai1 and KV1.3 channels[J]. Frontiers in Pharmacology, 2021, 12:685092.
[22] 杨波,郭建恩,韩俊婷,等. 龙血素A对大鼠局灶性脑缺血再灌注引起的脑损伤及机制探讨[J]. 中药新药与临床药理,2010,21(2):103-107. YANG Bo, GUO Jianen, HAN Junting, et al. Effect of loureirin A on focal cerebral ischemia-reperfusion rats and its mechanism[J]. Traditional Chinese Drug Research & Clinical Pharmacology, 2010, 21(2):103-107.
[23] LIU Y S, MI Y, WANG Y P, et al. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice[J]. Phytomedicine, 2023, 113:154729.
[24] SU X Q, SONG Y L, ZHANG J, et al. Dihydrochalcones and homoisoflavanes from the red resin of Dracaena cochinchinensis(Chinese dragonsblood)[J]. Fitoterapia, 2014, 99:64-71.
[25] CHENG L, JIN Z X, ZHAO R, et al. Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway[J]. International Journal of Clinical and Experimental Medicine, 2015, 8(7):10420-10428.
[26] JIANG M, SU X, LIU J L, et al. Systems pharmacology-dissection of the molecular mechanisms of dragons blood in improving ischemic stroke prognosis[J]. Evidence-Based Complementary and Alternative Medicine, 2020, 2020:4858201.
[27] 朱智德,吴玉强. 剑叶龙血树繁育种植技术与人工诱导机制研究综述[J]. 大众科技,2015,17(12):99-101. ZHU Zhide, WU Yuqiang. The research summarizes of D.cochinchinensis about breeding cultivation technology and artificial induction mechanism[J]. Popular Science & Technology, 2015, 17(12):99-101.
[1] 桂梁,徐遥,何世柱,张元哲,刘康,赵军. 基于动态邻居选择的知识图谱事实错误检测方法[J]. 《山东大学学报(理学版)》, 2024, 59(7): 76-84.
[2] 陆玮洁1 ,刘冰1,2 ,邹华彬1 ,张衡1 ,张新玲1 ,杨国生1 . 茶叶HNMR指纹图谱双指标序列分析[J]. J4, 2009, 44(3): 35-38 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!